Discounted Cash Flow (DCF) Analysis Unlevered

vTv Therapeutics Inc. (VTVT)

$0.7763

-0.02 (-2.66%)
All numbers are in Millions, Currency in USD
Stock DCF: 0.24 | 0.7763 | overvalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 12.432.766.410000000
Revenue (%)
EBITDA -4.20-11.08-7.71-0.01-0.02-0.01-0.01-0.01-0.01-0
EBITDA (%)
EBIT -4.42-11.12-7.81-0.01-0.02-0.01-0.01-0.01-0.01-0
EBIT (%)
Depreciation 0.220.040.090000000
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 1.681.785.7513.4112.133.993.382.862.432.06
Total Cash (%)
Account Receivables -00.160.060.170.050.040.030.030.02
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 2.902.231.930000000
Accounts Payable (%)
Capital Expenditure -0-0.07-0.08-0-0-0-0-0-0-0
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.7,763
Beta -1.106
Diluted Shares Outstanding 47.14
Cost of Debt
Tax Rate 22.95
After-tax Cost of Debt 0.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity -1.825
Total Debt 0.72
Total Equity 36.59
Total Capital 37.31
Debt Weighting 1.92
Equity Weighting 98.08
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 12.432.766.410000000
EBITDA -4.20-11.08-7.71-0.01-0.02-0.01-0.01-0.01-0.01-0
EBIT -4.42-11.12-7.81-0.01-0.02-0.01-0.01-0.01-0.01-0
Tax Rate 66.54%40.27%33.61%26.28%22.95%37.93%37.93%37.93%37.93%37.93%
EBIAT -1.48-6.64-5.18-0.01-0.01-0.01-0-0-0-0
Depreciation 0.220.040.090000000
Accounts Receivable ---0.150.10-0.120.130.010.010.010
Inventories ----------
Accounts Payable --0.67-0.31-1.92-0-0-0-0-0-0
Capital Expenditure -0.01-0.07-0.08-0-0-0-0-0-0-0
UFCF -1.27-7.34-5.63-1.83-0.130.120000
WACC
PV UFCF -0.130.120000
SUM PV UFCF 0.13

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -1.79
Free cash flow (t + 1) 0
Terminal Value -0.04
Present Value of Terminal Value -0.05

Intrinsic Value

Enterprise Value 0.09
Net Debt -11.41
Equity Value 11.50
Shares Outstanding 47.14
Equity Value Per Share 0.24